User profiles for Shawn D Aaron
Shawn AaronOttawa Hospital Research Institute, University of Ottawa Verified email at ohri.ca Cited by 22070 |
Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial
SD Aaron, KL Vandemheen, D Fergusson… - Annals of internal …, 2007 - acpjournals.org
Background: Treatment of moderate or severe chronic obstructive pulmonary disease (COPD)
with combinations of inhaled corticosteroids, long-acting β-agonists, and long-acting …
with combinations of inhaled corticosteroids, long-acting β-agonists, and long-acting …
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
When is it legitimate to exclude randomised patients from the analysis of data in clinical trials?
Basing their analysis on the desirability of minimising bias and random error, the authors …
Basing their analysis on the desirability of minimising bias and random error, the authors …
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease
SD Aaron, JB Angel, M Lunau, K Wright… - American journal of …, 2001 - atsjournals.org
There is increasing evidence that chronic obstructive pulmonary disease (COPD) is associated
with chronic inflammation in the airways and lung parenchyma; however, little is known …
with chronic inflammation in the airways and lung parenchyma; however, little is known …
Overdiagnosis of asthma in obese and nonobese adults
… Contributors: Shawn Aaron had full access to all of the data in the study and takes …
Shawn Aaron drafted the manuscript; the other authors revised the manuscript critically for …
Shawn Aaron drafted the manuscript; the other authors revised the manuscript critically for …
[HTML][HTML] Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease
Background In this randomized, double-blind, placebo-controlled trial, we studied the
effectiveness of prednisone in reducing the risk of relapse after outpatient exacerbations of chronic …
effectiveness of prednisone in reducing the risk of relapse after outpatient exacerbations of chronic …
Reevaluation of diagnosis in adults with physician-diagnosed asthma
SD Aaron, KL Vandemheen, JM FitzGerald, M Ainslie… - Jama, 2017 - jamanetwork.com
Importance Although asthma is a chronic disease, the expected rate of spontaneous
remissions of adult asthma and the stability of diagnosis are unknown. Objective To determine …
remissions of adult asthma and the stability of diagnosis are unknown. Objective To determine …
The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis
Background The relevance of Aspergillus fumigatus in patients with cystic fibrosis (CF) not
affected by allergic bronchopulmonary aspergillosis is unclear. Our aim was to determine the …
affected by allergic bronchopulmonary aspergillosis is unclear. Our aim was to determine the …
Effect of weight reduction on respiratory function and airway reactivity in obese women
Background Population-based studies have documented an association between obesity
and an increased prevalence of asthma in women. Methods We prospectively studied 58 …
and an increased prevalence of asthma in women. Methods We prospectively studied 58 …
Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections
R Saginur, M StDenis, W Ferris, SD Aaron… - Antimicrobial agents …, 2006 - Am Soc Microbiol
Standardized susceptibility testing fails to predict in vivo resistance of device-related infections
to antimicrobials. We assessed agents and combinations of antimicrobials against clinical …
to antimicrobials. We assessed agents and combinations of antimicrobials against clinical …
[HTML][HTML] Simvastatin for the prevention of exacerbations in moderate-to-severe COPD
GJ Criner, JE Connett, SD Aaron… - … England Journal of …, 2014 - Mass Medical Soc
Background Retrospective studies have shown that statins decrease the rate and severity of
exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary …
exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary …